Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers in connection with the divestment of Johan i Hallen & Bergfalk
Mandate

Vinge advises the sellers in connection with the divestment of Johan i Hallen & Bergfalk

May 04, 2023 Banking and Finance M&A

Vinge advises the sellers, represented by Litorina V Fund, in connection with the divestment of JOHBECO AB (including its Swedish and Finnish subsidiaries Johan i Hallen & Bergfalk) to METRO FSD Holding GmbH, an indirect subsidiary of international wholesaler METRO AG.

Johan i Hallen & Bergfalk operates on the Swedish and Finnish markets and is a leading Swedish specialist provider of high quality fresh proteins such as meat, fish and seafood to restaurants, hotels and cafés.

Vinge’s team consisted of Jonas Johansson, Carl Sander, Desirée Hagenfeldt and Robin Sultani (M&A) and Karl-Gustaw Tobola (Bank & Financing) as well as Julia Hagelberg, Emy Rydén and Anna Ekdahl Roos (project assistants).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025